logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yanping Liu

qilu hospital of shandong university
H指数:38
被引数:5,056

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Anbenitamab in combination with chemotherapy in patients with HER2-positive gastric or gastroesophageal junction carcinoma who failed previous therapy containing trastuzumab: a multicenter, phase II study (KC-WISE 01)

阿本替尼（anbenitamab）联合化疗用于既往接受过含曲妥珠单抗（trastuzumab）治疗失败的HER2阳性胃或胃食管结合部癌患者的治疗：一项多中心、II期研究（KC-WISE 01）。

CANCER COMMUNICATIONS
IF24.9
2025-11-010
OAAI
Zhao, Chuanhua; Zhao, Jun; Chen, Yigui; Liu, Bo; Du, Yangfeng; Li, Chenglin; Zhang, Jingdong; Yang, Mudan; Liu, Ying; Bai, Yuxian; Li, Suyi; Zhang, Ruixing; Ning, Fangling; Liu, Yanping; Zou, Kai; Zhang, Qi; Xie, Yijiao; An, Yuping; Xu, Jianming
An Automatic Deep-Radiomics Framework for Prostate Cancer Diagnosis and Stratification in Patients with Serum Prostate-Specific Antigen of 4.0-10.0 ng/mL: A Multicenter Retrospective Study

一种用于血清前列腺特异性抗原为4.0-10.0 ng/mL的患者的自动深度放射组学框架，用于前列腺癌诊断和分层：一项多中心回顾性研究

ACADEMIC RADIOLOGY
IF3.9
2025-01-011
PRE
Zheng, BW; Mo, FT; Shi, XR; Li, WH; Shen, QY; Zhang, L; Liao, ZJ; Fan, CE; Liu, YP; Zhong, JY; Qin, GG; Tao, J; Lv, SD; Wei, Q

研究方向

暂未获取到该数据
D
David D. Gutterman
H 指数:80论文数:390被引数:2.3万
C
Chad S. Hunter
H 指数:23论文数:80被引数:1,887
X
Xiuwen Zhou
H 指数:24论文数:122被引数:1,819
J
Jiaqi Tang
H 指数:22论文数:89被引数:1,084
J
Jan A. Staessen
H 指数:143论文数:1,927被引数:11.9万
K
Kirk M. Habegger
H 指数:34论文数:103被引数:6,675
M
Miao Sun
H 指数:44论文数:243被引数:7,496
T
Teayoun Kim
H 指数:20论文数:57被引数:1,555
J
Jessica D. Kepple
H 指数:7论文数:20被引数:185
Z
Zhice Xu
H 指数:29论文数:126被引数:2,450